97 related articles for article (PubMed ID: 7735740)
1. Magnetic resonance imaging in myelodysplastic syndromes.
Lewis S; Wainscoat JS; Moore NR; Golding SJ
Br J Radiol; 1995 Feb; 68(806):121-7. PubMed ID: 7735740
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of magnetic resonance imaging of femoral marrow in patients with myelodysplastic syndromes.
Takagi S; Tanaka O; Origasa H; Miura Y
J Clin Oncol; 1999 Jan; 17(1):277-83. PubMed ID: 10458243
[TBL] [Abstract][Full Text] [Related]
3. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
Oscier DG; Worsley A; Darlow S; Figes A; Williams JD; Hamblin TJ
Leuk Res; 1989; 13(9):833-9. PubMed ID: 2796388
[TBL] [Abstract][Full Text] [Related]
4. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance.
Werner M; Maschek H; Kaloutsi V; Choritz H; Georgii A
Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):47-52. PubMed ID: 1636249
[TBL] [Abstract][Full Text] [Related]
5. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
Baur AS; Meugé-Moraw C; Schmidt PM; Parlier V; Jotterand M; Delacrétaz F
Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326
[TBL] [Abstract][Full Text] [Related]
6. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
7. Are 'dysplastic' and hypogranular megakaryocytes specific markers for myelodysplastic syndrome?
Wong KF; Chan JK
Br J Haematol; 1991 Apr; 77(4):509-14. PubMed ID: 2025576
[TBL] [Abstract][Full Text] [Related]
8. [Magnetic resonance imaging of the bone marrow in patients with aplastic anemia and myelodysplastic syndrome].
Kusumoto S
Rinsho Ketsueki; 1992 Apr; 33(4):423-9. PubMed ID: 1602604
[TBL] [Abstract][Full Text] [Related]
9. Unusual specific cutaneous lesions in myelodysplastic syndromes.
Aractingi S; Bachmeyer C; Miclea JM; Vérola O; Rousselot P; Dubertret L; Daniel MT
J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):187-91. PubMed ID: 7622643
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
Omine M; Yamauchi H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
[TBL] [Abstract][Full Text] [Related]
12. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
Galton DA
Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
[No Abstract] [Full Text] [Related]
13. Refractory anemia with ringed sideroblasts and chronic myelomonocytic leukemia: myelodysplastic/myeloproliferative disease.
D'Angelo G
Lab Hematol; 2005; 11(3):171-3. PubMed ID: 16174602
[TBL] [Abstract][Full Text] [Related]
14. Mixed myelodysplastic and myeloproliferative syndromes.
Neuwirtová R; Mociková K; Musilová J; Jelínek J; Havlícek F; Michalová K; Adamkov M
Leuk Res; 1996 Sep; 20(9):717-26. PubMed ID: 8947580
[TBL] [Abstract][Full Text] [Related]
15. Classification of the myelodysplastic syndromes.
Bennett JM
Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
[No Abstract] [Full Text] [Related]
16. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
[TBL] [Abstract][Full Text] [Related]
17. A specific cutaneous lesion revealing myelodysplastic syndrome.
Kajisawa C; Matsui C; Morohashi M
Eur J Dermatol; 1998; 8(7):517-8. PubMed ID: 9854168
[TBL] [Abstract][Full Text] [Related]
18. [MR imaging findings of the femoral marrow in myelodysplastic syndrome].
Tanaka O; Takagi S; Matsuura K; Ichikawa T; Kobayashi Y; Nagai J
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Oct; 55(12):837-44. PubMed ID: 8539101
[TBL] [Abstract][Full Text] [Related]
19. Trilineage extramedullary myeloid cell tumor in myelodysplastic syndrome.
Hancock JC; Prchal JT; Bennett JM; Listinsky CM
Arch Pathol Lab Med; 1997 May; 121(5):520-3. PubMed ID: 9167610
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
